Published November 15, 2016 | Version v1
Journal article

Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer

  • 1. National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg (Germany)
  • 2. Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg (Germany)
  • 3. Department of Radiation Oncology Kempten, Robert-Weixler-Straße 50, 87439 Kempten (Germany)
  • 4. Department of Medical Physics in Radiation Oncology, German Cancer Research Center (dkfz), Im Neuenheimer Feld 280, 69120 Heidelberg (Germany)
  • 5. Department of Radiation Oncology Baden-Baden, Balger Straße 50, 76532 Baden-Baden (Germany)

Description

In carbon ion radiotherapy (CIR) for esophageal cancer, organ and target motion is a major challenge for treatment planning due to potential range deviations. This study intends to analyze the impact of intrafractional variations on dosimetric parameters and to identify favourable settings for robust treatment plans. We contoured esophageal boost volumes in different organ localizations for four patients and calculated CIR-plans with 13 different beam geometries on a free-breathing CT. Forward calculation of these plans was performed on 4D-CT datasets representing seven different phases of the breathing cycle. Plan quality was assessed for each patient and beam configuration. Target volume coverage was adequate for all settings in the baseline CIR-plans (V95 > 98% for two-beam geometries, > 94% for one-beam geometries), but reduced on 4D-CT plans (V95 range 50–95%). Sparing of the organs at risk (OAR) was adequate, but range deviations during the breathing cycle partly caused critical, maximum doses to spinal cord up to 3.5x higher than expected. There was at least one beam configuration for each patient with appropriate plan quality. Despite intrafractional motion, CIR for esophageal cancer is possible with robust treatment plans when an individually optimized beam setup is selected depending on tumor size and localization.

Availability note (English)

Available from http://dx.doi.org/10.1186/s13014-016-0727-2; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109696

Additional details

Identifiers

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
11
Journal Page Range
vp.
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49082305
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BEAMS; CARBON IONS; NEOPLASMS; PATIENTS; RADIATION DOSES; RADIATION HAZARDS; RADIOTHERAPY
Descriptors DEC
CHARGED PARTICLES; DISEASES; DOSES; HAZARDS; HEALTH HAZARDS; IONS; MEDICINE; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) The Author(s). 2016
Notes
PMCID: PMC5109696; PMID: 27846916; PMID: 27846916; PUBLISHER-ID: 727; OAI: oai:pubmedcentral.nih.gov:5109696